Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00757744 · ClinicalTrials.gov registry record · Phase 3
Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China
A Phase 3 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
- 45
- Enrollment target
NCT00757744: Completed Phase 3 study, sponsored by Yale University.
NCT00757744 is a Phase 3 study that has completed, run by Yale University. The registered enrollment target is 45 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00757744, a Phase 3 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 45 participants
- Enrollment target
Study Summary
A randomized clinical trial evaluating the reduction of HIV risk behaviors and drug use when providing integrated behavioral drug and HIV risk reduction counseling (BDRC) along with methadone maintenance treatment in Wuhan, China
Interventions
- BEHAVIORAL Behavioral Drug and HIV Risk Reduction Counseling (BDRC)
- BEHAVIORAL Drug counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2007-09 |
| Est. Completion | 2010-09 |
| Phase | Phase 3 |
What the finished NCT00757744 record still lists
NCT00757744 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Behavioral Drug and HIV Risk Reduction Counseling (BDRC) is the first listed.
NCT00757744 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00757744 about?
NCT00757744 is a clinical study titled "Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China". A randomized clinical trial evaluating the reduction of HIV risk behaviors and drug use when providing integrated behavioral drug and HIV risk reduction counseling (BDRC) along with methadone maintenance treatment in Wuhan, China
What is the current status of trial NCT00757744?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 45 participants. The study started on 2007-09. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00757744?
The interventions under investigation include: Behavioral Drug and HIV Risk Reduction Counseling (BDRC) (BEHAVIORAL), Drug counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00757744?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00757744's enrollment target sits among peer trials
45 1870th of 2000 higher than 127 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia